Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

IL-5 receptor ligands reported by Glaxo Wellcome

Dec. 31, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

Teijin starts clinical trials of in-licensed antiasthmatic drug

Dec. 24, 1997

Boehringer Ingelheim to develop and market Procysteine in Japan

Dec. 24, 1997

Jouveinal patents PDE IV inhibitors

Dec. 24, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...